Comparable stake leader
Bradley L. Radoff
SEC ownership of Guardion Health Sciences, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001642375.
Disclosed value leader
Bret Scholtes
Comparable rows
0/10
Latest evidence
26 Aug 2024
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Bradley L. Radoff
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
26 Aug 2024
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001642375
- Issuer location
- Houston, TX
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Guardion Health Sciences, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bradley L. Radoff
Disclosed value leader
Bret Scholtes
Comparable rows
0/10
Latest evidence
26 Aug 2024
3/4/5
Highest disclosed value: $2,359,516
10 rows are not safely comparable across share classes.
Showing 1-8 of 10 holder rows.
Quick read
Bret Scholtes has the largest disclosed position value at $2.36M.
0 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Bret Scholtes's linked filing trail.
Disclosed position value
Top 2
Bradley L. Radoff
$1.98M
Bret Scholtes
$2.36M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 10 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bradley L. Radoff |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$1,980,387
127,460 shares
|
— | 26 Aug 2024 |
| GREAT POINT CAPITAL LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
159,652 shares
|
— | 28 Mar 2024 |
| Bret Scholtes |
3/4/5
CEO and President, Director
|
—
class O/S missing
|
$2,359,516
294,980 shares
|
— | 06 Jan 2022 |
| Craig Sheehan |
3/4/5
Chief Commercial Officer
|
—
mixed-class rows
|
—
100,000 shares
mixed-class rows
|
— | 02 Jun 2021 |
| Kelly Anderson |
3/4/5
Director
|
—
class O/S missing
|
—
16,667 shares
|
— | 30 Jun 2021 |
| Janet Hall |
3/4/5
CEO & President
|
—
class O/S missing
|
—
10,000 shares
|
— | 30 May 2023 |
| Donald A. Gagliano |
3/4/5
Director
|
—
class O/S missing
|
—
334 shares
|
— | 30 Jun 2023 |
| Mark Goldstone |
3/4/5
Director
|
—
class O/S missing
|
—
334 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 20 Sep 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-12 of 12 reporting-owner rows connected to Guardion Health Sciences, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
12
Largest Forms 3/4/5 holder
Bret Scholtes
Net 12M change
$0
Latest report
26 Aug 2024
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Bret Scholtes | CEO and President, Director | $2,359,516 | Mixed | 06 Jan 2022 | ||
| Bradley L. Radoff | 10%+ Owner | $1,980,387 | Filing P/S | 26 Aug 2024 | ||
| Jeffrey S. Benjamin | Chief Accounting Officer | Mixed | 01 Aug 2021 | |||
| Craig Sheehan | Chief Commercial Officer | Mixed | 02 Jun 2021 | |||
| Donald A. Gagliano | Director | Mixed | 30 Jun 2023 | |||
| Mark Goldstone | Director | Mixed | 30 Jun 2023 | |||
| GREAT POINT CAPITAL LLC | 10%+ Owner | Mixed | 28 Mar 2024 | |||
| Kelly Anderson | Director | Mixed | 30 Jun 2021 | |||
| Michaela Griggs | Director | Mixed | 30 Jun 2023 | |||
| Janet Hall | CEO & President | Mixed | 30 May 2023 | |||
| Katharine Joan Cox | Chief Accounting Officer | Mixed | 25 Jul 2023 | |||
| Robert N. Weingarten | Director | Mixed | 30 Jun 2023 |
Recent insider transactions for Guardion Health Sciences, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.